4th ASM Conference on Beneficial Microbes

第四届 ASM 有益微生物会议

基本信息

  • 批准号:
    8399967
  • 负责人:
  • 金额:
    $ 0.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-13 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The combination of rapid technological advances and the development of new experimental model systems has propelled the area of beneficial microbes forward. Research over the last several years has provided overwhelming evidence that the health of humans, and likely most other animals, is dependent upon their associations with persistent, coevolved communities of microorganisms. Not only do these consortia of beneficial microbes play a critical role in day-to-day physiological homeostasis, but also they partner with the host's immune system to successfully resist pathogenesis. This latter role has taken on an increasing significance in an age of emerging infectious diseases and immunocompromised patients. The unprecedented advances in DNA sequencing technologies and associated bioinformatics analyses are now allowing researchers to transition from studying the composition of microbial communities to elucidating their metabolic potential even in complex host- associated microbial communities. The advances of "omics" approaches, i.e. transcriptomics, proteomics and metabolomics, are now helping to reveal the basis of host-microbe interactions at a functional level. The successful application of these approaches should elucidate the function of the microbiome and provide mechanistic insights into the interaction of microbial communities. The ASM Beneficial Microbes conferences are internationally attended meetings that bring together biologists in areas ranging from molecular genetics to metagenomics to systems biology and ecology to discuss the development of this frontier field of research. Based on the recent advances in the field, we obtained sponsorship from American Society for Microbiology (ASM) to organize a new Beneficial Microbe conference "Functional and Mechanistic Insights into Host-Microbe Interactions". We are requesting funding for the support of United States and international scientists attending the upcoming meeting to be held in San Antonio, Texas, October 22-26, 2012. The meeting has six sessions devoted to exploring the current state of the field and defining new directions of inquiry. (i) "Functional Analysis of the Human Microbiome" will highlight new functional insights gained by transcriptomics, proteomics and metabolomics studies. (ii) "Role of Beneficial Microbes in Health and Disease" will have talks presenting results from animal models and clinical studies. (iii) "Inter-kingdom Signaling" will feature presentations from model systems that revealed broadly applicable molecular signaling. (iv) "Beneficial Microbe-Immune System Interactions" will feature research describing how beneficial microbes interact with the host immune system. (v) "Role of Beneficial Microbes in the Environment" will feature speakers that have pioneered approaches in environmental systems that are of direct relevance to medically important systems. (vi) "Systems Biology of Symbiotic Systems" will present whole systems approaches and analyses. PUBLIC HEALTH RELEVANCE: The role of beneficial microbes in health of humans is a new research area that represents a dramatic shift in the perception of microbes in general. The NIH funded human microbiome project has revealed the diversity of microorganisms that live in close association in and on the human body. They contribute to the health not only by preventing pathogenic bacteria from colonizing but by providing essential nutrients, stimulating the immune system and influencing the development. The goal of the 2012 meeting will be to emphasis on how metagenomics, metabolomics, and computational biology and modeling can be used to better understand host-microbe interactions. Understanding the role of microbes in health is critical to understand how disturbing the microbiome can lead to disease.
描述(由申请人提供):快速的技术进步和新实验模型系统的开发相结合,推动了有益微生物领域的发展。过去几年的研究提供了压倒性的证据,表明人类以及大多数其他动物的健康取决于他们与持久的、共同进化的微生物群落的关系。这些有益微生物群不仅在日常生理稳态中发挥着关键作用,而且还与宿主的免疫系统合作,成功抵抗发病机制。在新出现的传染病和免疫功能低下患者的时代,后一种作用变得越来越重要。 DNA 测序技术和相关生物信息学分析的前所未有的进步现在使研究人员能够从研究微生物群落的组成过渡到阐明其代谢潜力,甚至在复杂的宿主相关微生物群落中也是如此。 “组学”方法,即转录组学、蛋白质组学和代谢组学的进步,现在正在帮助揭示功能水平上宿主-微生物相互作用的基础。这些方法的成功应用应该阐明微生物组的功能,并为微生物群落的相互作用提供机制见解。 ASM 有益微生物会议是国际性会议,汇集了分子遗传学、宏基因组学、系统生物学和生态学等领域的生物学家,讨论这一前沿研究领域的发展。基于该领域的最新进展,我们获得了美国微生物学会(ASM)的赞助,组织了新的有益微生物会议“宿主-微生物相互作用的功能和机制见解”。我们正在请求资金支持参加即将于 2012 年 10 月 22 日至 26 日在德克萨斯州圣安东尼奥举行的会议的美国和国际科学家。该会议有六场会议,专门探讨该领域的现状并确定新的研究方向。 (i)“人类微生物组的功能分析”将重点介绍通过转录组学、蛋白质组学和代谢组学研究获得的新的功能见解。 (ii) “有益微生物在健康和疾病中的作用”将进行演讲,介绍动物模型和临床研究的结果。 (iii)“王国间信号传导”将重点介绍揭示广泛适用的分子信号传导的模型系统。 (iv)“有益微生物-免疫系统相互作用”将重点研究描述有益微生物如何与宿主免疫系统相互作用。 (v) “有益微生物在环境中的作用”将由在与重要医学系统直接相关的环境系统中开创性方法的演讲者担任。 (vi)“共生系统的系统生物学”将介绍整个系统的方法和分析。 公共卫生相关性:有益微生物在人类健康中的作用是一个新的研究领域,它代表了人们对微生物的总体看法的巨大转变。美国国立卫生研究院资助的人类微生物组项目揭示了与人体内部和表面密切相关的微生物的多样性。它们不仅可以防止病原菌定植,还可以提供必需的营养物质、刺激免疫系统并影响发育,从而对健康做出贡献。 2012 年会议的目标将是强调如何利用宏基因组学、代谢组学以及计算生物学和建模来更好地了解宿主-微生物相互作用。了解微生物在健康中的作用对于了解干扰微生物组如何导致疾病至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOERG GRAF其他文献

JOERG GRAF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOERG GRAF', 18)}}的其他基金

Functional Analysis of a Digestive-Tract Microbiome During Dietary Changes
饮食变化期间消化道微生物组的功能分析
  • 批准号:
    8591395
  • 财政年份:
    2010
  • 资助金额:
    $ 0.9万
  • 项目类别:
Functional Analysis of a Digestive-Tract Microbiome During Dietary Changes
饮食变化期间消化道微生物组的功能分析
  • 批准号:
    8015151
  • 财政年份:
    2010
  • 资助金额:
    $ 0.9万
  • 项目类别:
Functional Analysis of a Digestive-Tract Microbiome During Dietary Changes
饮食变化期间消化道微生物组的功能分析
  • 批准号:
    8387757
  • 财政年份:
    2010
  • 资助金额:
    $ 0.9万
  • 项目类别:
Functional Analysis of a Digestive-Tract Microbiome During Dietary Changes
饮食变化期间消化道微生物组的功能分析
  • 批准号:
    8197896
  • 财政年份:
    2010
  • 资助金额:
    $ 0.9万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 0.9万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 0.9万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 0.9万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 0.9万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 0.9万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了